Trial · NCT01359969
Adverse events33
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 33
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Lymphocyte morphology abnormal | Vascular disorders | Recombinant Human C1 Inhibitor | 2 | 20 | 2 |
| other | Pallor | Vascular disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Body temperature increased | Vascular disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Catarrh | Respiratory, thoracic and mediastinal disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Pharyngeal oedema | Respiratory, thoracic and mediastinal disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Headache | Nervous system disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Eye swelling | Eye disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Middle ear effusion | Ear and labyrinth disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Nasopharyngitis | Infections and infestations | Recombinant Human C1 Inhibitor | 3 | 20 | 3 |
| other | Viral infection | Infections and infestations | Recombinant Human C1 Inhibitor | 2 | 20 | 2 |
| other | Bronchitis | Infections and infestations | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Pharyngitis streptococcal | Infections and infestations | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Pharyngotonsillitis | Infections and infestations | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Pneumonia | Infections and infestations | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Tonsillitis | Infections and infestations | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Upper respiratory tract infection | Infections and infestations | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
| other | Vomiting | Gastrointestinal disorders | Recombinant Human C1 Inhibitor | 3 | 20 | 3 |
| other | Abdominal pain | Gastrointestinal disorders | Recombinant Human C1 Inhibitor | 1 | 20 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01359969/events